Doctor Naren Basu is the Lead Consultant Oncoplastic Breast Surgeon at the Queen Elizabeth Hospital, Birmingham, UK.

He qualified from St Bartholomew’s and the Royal London Hospital, London. During his medical school training, he undertook an additional degree to study the biology of cancer (Tumor Biology) at the University College London, for which he was awarded a first-class degree.

During his higher surgical training, he completed a Master’s degree at Imperial College, London evaluating technological advances in surgery and the practical multi-disciplinary approach to implementing this technology.

In 2013, he was awarded the National Oncoplastic Fellowship for his year spent in Manchester. He was also awarded a doctorate of medicine by the University of Manchester for his research into risk factors for developing contralateral breast cancer amongst women with a mutation in BRCA1 BRCA2 genes which culminated in the formulation of the Manchester Guidelines.

He is an active trainer of the plastic and breast surgeons of the future at a national and international level. In addition, he holds the position of Honorary Senior Clinical Lecturer at the University of Birmingham and is responsible for training tomorrow’s doctors.